Read My Lips: Advanced Cell Technology Will Make You Rich... In 2014!
Jan. 26, 2014 1:44 PM ET | About: ACTC
Disclosure: I am long ACTC. (More...)
(Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the
risks associated with these stocks.) Advanced Cell Technology (OTCQB:ACTC) has got to be one of the most kicked around, blatantly abused stocks of all time. And, although I can certainly cast a whole lot of blame on at least one of the "dearly departed", former CEO Gary Rabin, far too much of the positive developments simply gets passed over as though some of the seriously genius accomplishments have never occurred.
Look, I don't make a living pumping stocks, and I won't start here. What I will do, however, is to point out the pieces to a very complex and dynamic company. And yes, I am still talking about Advanced Cell Technology.
Don't misunderstand me, I have certainly had my frustrations, but I can also tell you that I have held this little, soon-to-be-gem in my crown stock, for a period longer than most would ever admit. No, I don't micromanage the price of the stock daily, and no, I don't throw stones at a penny stock that has had to turn to alternative financing to fund operations. Advanced Cell is not the first, and they will be far from the last to execute milestones off the backs of some of those vultures who offer those pesky little convertible debentures surrounded in a basket of beautiful flowers. Yeah, you know the ones because some of your other stocks have fallen prey to them as well, right? Well, in that case, take a deep breath and exhale that negativity, because I don't want to discuss that either
AI
